Source:http://linkedlifedata.com/resource/pubmed/id/17567829
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2007-7-3
|
pubmed:abstractText |
To optimize the management of patients with chronic hepatitis C virus (HCV) infection, noninvasive tests to determine the degree of hepatic fibrosis have been developed. The aims of this study were (1) to validate a simple, inexpensive, noninvasive test called FIB-4, which combines standard biochemical values (platelets, ALT, AST) and age, in a series of 847 liver biopsies performed in HCV-monoinfected patients; and (2) to compare the results of 780 FIB-4 and FibroTests performed the same day in a series of 592 HCV-infected patients. The FIB-4 index enabled the correct identification of patients with severe fibrosis (F3-F4) and cirrhosis with an area under the receiver operating characteristic curve of 0.85 (95% CI 0.82-0.89) and 0.91 (95% CI 0.86-0.93), respectively. An FIB-4 index <1.45 had a negative predictive value of 94.7% to exclude severe fibrosis with a sensitivity of 74.3%. An FIB-4 index higher than 3.25 had a positive predictive value to confirm the existence of a significant fibrosis (F3-F4) of 82.1% with a specificity of 98.2%. Using these ranges, 72.8% of the 847 liver biopsies were correctly classified. The FIB-4 index was strongly correlated to the FibroTest results for a score <1.45 or >3.25 (kappa = 0.561, P < 0.01). A FIB-4 value <1.45 or >3.25 (64.6% of the cases) was concordant with FibroTest results in 92.1% and 76%, respectively. CONCLUSION: For values outside 1.45-3.25, the FIB-4 index is a simple, accurate, and inexpensive method for assessing liver fibrosis and proved to be concordant with FibroTest results.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0270-9139
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
32-6
|
pubmed:dateRevised |
2008-3-11
|
pubmed:meshHeading |
pubmed-meshheading:17567829-Adult,
pubmed-meshheading:17567829-Alanine Transaminase,
pubmed-meshheading:17567829-Aspartate Aminotransferases,
pubmed-meshheading:17567829-Biological Markers,
pubmed-meshheading:17567829-Hepatitis C,
pubmed-meshheading:17567829-Humans,
pubmed-meshheading:17567829-Liver Cirrhosis,
pubmed-meshheading:17567829-Liver Function Tests,
pubmed-meshheading:17567829-Middle Aged,
pubmed-meshheading:17567829-Patient Selection,
pubmed-meshheading:17567829-Platelet Count,
pubmed-meshheading:17567829-Predictive Value of Tests,
pubmed-meshheading:17567829-RNA, Viral,
pubmed-meshheading:17567829-Reference Values,
pubmed-meshheading:17567829-Reproducibility of Results,
pubmed-meshheading:17567829-Viral Load
|
pubmed:year |
2007
|
pubmed:articleTitle |
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.
|
pubmed:affiliation |
Université Paris-Descartes, Paris, France.
|
pubmed:publicationType |
Journal Article
|